ES2836374T3 - Conjugados de nitrooxi-cromeno que liberan NO - Google Patents

Conjugados de nitrooxi-cromeno que liberan NO Download PDF

Info

Publication number
ES2836374T3
ES2836374T3 ES15737116T ES15737116T ES2836374T3 ES 2836374 T3 ES2836374 T3 ES 2836374T3 ES 15737116 T ES15737116 T ES 15737116T ES 15737116 T ES15737116 T ES 15737116T ES 2836374 T3 ES2836374 T3 ES 2836374T3
Authority
ES
Spain
Prior art keywords
cancer
compound
radical
methyl
chromene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES15737116T
Other languages
English (en)
Spanish (es)
Inventor
John Talley
Eduardo Martinez
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Euclises Pharmaceuticals Inc
Original Assignee
Euclises Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Euclises Pharmaceuticals Inc filed Critical Euclises Pharmaceuticals Inc
Application granted granted Critical
Publication of ES2836374T3 publication Critical patent/ES2836374T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/3533,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/52Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an inorganic compound, e.g. an inorganic ion that is complexed with the active ingredient
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems
    • C07D491/044Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
    • C07D491/048Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being five-membered

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
ES15737116T 2014-01-14 2015-01-14 Conjugados de nitrooxi-cromeno que liberan NO Active ES2836374T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201461927344P 2014-01-14 2014-01-14
PCT/US2015/011454 WO2015109011A1 (en) 2014-01-14 2015-01-14 No-releasing nitrooxy-chromene conjugates

Publications (1)

Publication Number Publication Date
ES2836374T3 true ES2836374T3 (es) 2021-06-24

Family

ID=53543408

Family Applications (1)

Application Number Title Priority Date Filing Date
ES15737116T Active ES2836374T3 (es) 2014-01-14 2015-01-14 Conjugados de nitrooxi-cromeno que liberan NO

Country Status (10)

Country Link
US (1) US10266511B2 (https=)
EP (1) EP3094333B1 (https=)
CN (1) CN106102747A (https=)
AU (1) AU2015206528B2 (https=)
BR (1) BR112016016386B1 (https=)
CA (1) CA2936952C (https=)
ES (1) ES2836374T3 (https=)
IL (1) IL246794B (https=)
MX (1) MX369245B (https=)
WO (2) WO2015109011A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105585547A (zh) * 2016-03-09 2016-05-18 中国科学院广州生物医药与健康研究院 一种4-五氟化硫苯酚类化合物及制备方法以及五氟化硫取代苯并吡喃类化合物的制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050101563A1 (en) 2001-08-14 2005-05-12 Pharmacia Corporation Method and compositions for the treatment and prevention of pain and inflammation
ITMI20021391A1 (it) 2002-06-25 2003-12-29 Nicox Sa Nitroderivati di inibitori della cicloossigenasi-2
EP1562914A1 (en) 2002-10-22 2005-08-17 Merck Frosst Canada & Co. Nitric oxide releasing selective cyclooxygenase-2 inhibitors
EP1603933A2 (en) * 2003-03-13 2005-12-14 Nitromed, Inc. Nitrosated and nitrosylated compounds, compositions and methods of use
US7259266B2 (en) 2003-03-31 2007-08-21 Pharmacia Corporation Benzopyran compounds useful for treating inflammatory conditions
US20050148627A1 (en) 2003-03-31 2005-07-07 Jeffery Carter Benzopyran compounds for use in the treatment and prevention of inflammation related conditions
EP1692107A4 (en) * 2003-12-10 2008-10-29 Nitromed Inc NITROGEN OXIDE-RELATED PYRUVATE COMPOUNDS, COMPOSITIONS AND USE METHOD
WO2006040646A1 (en) * 2004-10-14 2006-04-20 Pfizer, Inc. Benzimidazole or indole amides as inhibitors of pin1
WO2009009776A2 (en) 2007-07-12 2009-01-15 Tragara Pharmaceuticals, Inc. Patient selection and therapeutic methods using markers of prostaglandin metabolism
CN103012350B (zh) * 2012-12-07 2015-02-04 中国科学院广州生物医药与健康研究院 苯并吡喃类手性化合物的合成方法

Also Published As

Publication number Publication date
EP3094333A4 (en) 2017-09-06
MX2016009222A (es) 2017-03-06
EP3094333B1 (en) 2020-10-14
CA2936952C (en) 2023-01-24
CN106102747A (zh) 2016-11-09
US20160340330A1 (en) 2016-11-24
WO2015109013A1 (en) 2015-07-23
CA2936952A1 (en) 2015-07-23
BR112016016386B1 (pt) 2023-02-23
BR112016016386A2 (https=) 2017-08-08
AU2015206528B2 (en) 2019-04-18
MX369245B (es) 2019-11-01
WO2015109011A1 (en) 2015-07-23
IL246794A0 (en) 2016-08-31
IL246794B (en) 2020-04-30
EP3094333A1 (en) 2016-11-23
US10266511B2 (en) 2019-04-23
AU2015206528A1 (en) 2016-08-04

Similar Documents

Publication Publication Date Title
ES2927851T3 (es) Sulfonamidas y composiciones de las mismas para tratar afecciones asociadas con la actividad de NLRP
ES2927777T3 (es) Compuestos y composiciones para el tratamiento de afecciones asociadas a la actividad de NLRP
ES2526541T3 (es) N-sulfonilbenzamidas como inhibidores de canales de sodio dependientes de voltaje
ES2526981T3 (es) N-sulfonilbenzamidas como inhibidores de canales de sodio dependientes de voltaje
TWI798470B (zh) 作為神經激肽-1受體拮抗劑的化合物及其用途
AU2019250163A1 (en) Compositions and methods of modulating 15-PGDH activity
TW202014186A (zh) 作為核轉運調節劑之化合物及其用途
ES2608640T3 (es) Derivados de imidazopiridazina como moduladores del receptor GABAA
ES2871673T3 (es) Activador de los canales KCNQ2-5
ES2894919T3 (es) Inhibidores de MCT4 para el tratamiento de enfermedades
CN117597341A (zh) 磺酰胺衍生物、其制备方法及其在医药上的应用
ES2371932T3 (es) Derivados de pirazina como moduladores de los canales de sodio para el tratamiento del dolor.
WO2016155545A1 (zh) 含氨磺酰基的1,2,5-噁二唑类衍生物、其制备方法及其在医药上的应用
CN107033097B (zh) 噁二唑类衍生物、其制备方法及其在医药上的应用
WO2019118851A1 (en) Small molecule degraders that recruit dcaft15
AU2002248693A2 (en) Agents and methods for treatment of cancer
US20150197500A1 (en) No-releasing guanidine-chromene conjugates
ES2836374T3 (es) Conjugados de nitrooxi-cromeno que liberan NO
WO2015109014A1 (en) No-releasing nonoate(oxygen-bound)chromene conjugates
US20200277278A1 (en) Deuterium Atom-Substituted Indole Formamide Derivative, Preparation Method Therefor, and Medical Applications Thereof
US9044464B2 (en) No-releasing guanidine-coxib anti-cancer agents
HK1226644A1 (en) No-releasing nitrooxy-chromene conjugates
US20150197494A1 (en) No-releasing nitrooxy-methylene-linked-coxib conjugates
HK40130127A (zh) 用於治疗癌症及炎性疾病的咪唑幷[1,2-a]吡啶化合物及其制备所述化合物的方法
KR20260029377A (ko) 암 및 염증성 질환 치료에 사용하기 위한 이미다조[1,2-α]피리딘 화합물 및 그 화합물의 제조 방법